In last trading session, Windtree Therapeutics Inc (NASDAQ:WINT) saw 0.79 million shares changing hands with its beta currently measuring 0.56. Company’s recent per share price level of $0.44 trading at $0.06 or 14.78% at ring of the bell on the day assigns it a market valuation of $3.70M. That closing price of WINT’s stock is at a discount of -4100.0% from its 52-week high price of $18.48 and is indicating a premium of 36.36% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.23 million shares which gives us an average trading volume of 257.77K if we extend that period to 3-months.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Upright in the green during last session for gaining 14.78%, in the last five days WINT remained trading in the green while hitting it’s week-highest on Friday, 04/12/24 when the stock touched $0.44 price level, adding 8.92% to its value on the day. Windtree Therapeutics Inc’s shares saw a change of -39.50% in year-to-date performance and have moved 2.67% in past 5-day. Windtree Therapeutics Inc (NASDAQ:WINT) showed a performance of 16.94% in past 30-days. Number of shares sold short was 39650.0 shares which calculate 0.62 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 55.63% during past 5 years.
WINT Dividends
Windtree Therapeutics Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Insiders are in possession of 4.65% of company’s total shares while institution are holding 12.92 percent of that, with stock having share float percentage of 13.55%. Investors also watch the number of corporate investors in a company very closely, which is 12.92% institutions for Windtree Therapeutics Inc that are currently holding shares of the company. Virtu Financial LLC is the top institutional holder at WINT for having 42667.0 shares of worth $53333.0. And as of Jun 29, 2023, it was holding 0.83% of the company’s outstanding shares.
The second largest institutional holder is Acadian Asset Management. LLC, which was holding about 31583.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 0.61% of outstanding shares, having a total worth of $39478.0.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 8882.0 shares of worth $11102.0 or 0.17% of the total outstanding shares. The later fund manager was in possession of 2548.0 shares on May 30, 2023, making its stake of worth around $3261.0 in the company or a holder of 0.05% of company’s stock.
